EMERALD · Enzyme-integrated high-throughput Multicomponent synthesis for Echo-enabled Rapid molecule generation and Assay in Lead Discovery
„Хоризонт Европа“ — Действия „Мария Склодовска-Кюри“
- Период
- 2026-04-01 → 2028-03-31
- Финансиране от ЕС
- 191 918 €
- Участници
- 2
- Схема
- HORIZON-TMA-MSCA-PF-EF
Линиите свързват координатора с партньорите.
Накратко на български
Индолите, които се срещат в много лекарства, ще се модифицират чрез автоматизиран процес с ензими и минимално количество разтворители. Това помага за по-бързото и екологичното създаване на нови молекули, които могат да се тестват за борба с рака.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Цел на проекта
Indoles are among the most widely encountered scaffolds in medicines and natural products, yet general strategies for their systematic diversification remain limited. Through EMERALD (Enzyme-integrated high-throughput Multicomponent synthesis for Echo enabled Rapid molecule generation and Assay in Lead Discovery), I will unites three complementary techniques into the first miniaturized, automated pipeline for late-stage indole diversification at nanoliter scale (i) multicomponent reactions for efficient and modular assembly of indole frameworks; (ii) enzymatic tailoring, enabling regio- and chemoselective functionalization; and (iii) acoustic droplet ejection combined with real-time mass spectrometry, delivering ultra-high throughput synthesis and analytics with >90% reductions in solvent use. During a secondment at the University of St Andrews, I will evaluate enzyme panels to produce compatibility and selectivity maps directly relevant to drug discovery. Importantly, a subset of the resulting functionalized indoles will be screened against the p53–MDM2 interaction, a clinically validated target in oncology, to demonstrate the platforms’ direct translational potential. By marrying chemical and enzymatic methodologies, EMERALD establishes a sustainable route to novel scaffolds and natural product–inspired analogues, while providing an ideal interdisciplinary training ground at the interface of chemistry, biocatalysis, and automation-ultimately advancing greener drug discovery and fostering my path to research independence.
Оригинален текст от CORDIS (на английски).
Участници
- UNIVERZITA PALACKEHO V OLOMOUCI · OlomoucКоординаторЧехия
- THE UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS · ST ANDREWSОбединеното кралство
Връзки
Данни: CORDIS, © Европейски съюз
